AzTrials
AzTrials

Oocyte RetrievalHypnoPONCT05567315

Interest of Hypnosis in Virtual Reality on Nociception During Oocyte Retrieval in a Medically Assisted Reproduction Procedure

A study testing local anaesthetic injection and hypnosis with Virtual reality mask in people with Oocyte Retrieval, run by Clinique Mutualiste la Sagesse at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study on the effect of the virtual hypnosis mask in addition to local anaesthesia on anxiety and perioperative pain during oocyte puncture Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Oocyte Retrieval
What is being tested?
local anaesthetic injection and hypnosis with Virtual reality mask
Could I receive a placebo?
No, everyone receives an active treatment
How many people
182 participants
Where
1 siteFrance
Study dates
11 Oct 2022to 26 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patient having an oocyte puncture as part of a medically assisted procreation procedure
  • Surgical procedure planned in the operating theatre under local anaesthesia at the Clinique Mutualiste La Sagesse
  • Patient capable of receiving and understanding information about the study and giving written informed consent.
  • Affiliated to a social security system

Who cannot join

  • Patient's refusal to participate in a study
  • Patient having an oocyte retrieval as part of an oocyte donation
  • Unbalanced epilepsy.
  • Hearing and/or visual impairments that contraindicate the use of the virtual reality headset.
  • Patient with a poor understanding of the French language.
  • Medical indication to carry out the oocyte puncture under general anaesthesia
  • Drug allergy or hypersensitivity to PARACETAMOL - IBUPROFEN or NEFOPAM prescribed during the pre-medication.
  • Patient under legal protection

Trial locations and contacts

1 site in 1 country.

France1 site
  • Clinique mutualiste La Sagesse

    Rennes, Brittany Region, 35043

Other trials in France

About this study

Official title: Interest of Hypnosis in Virtual Reality on Nociception During Oocyte Retrieval in a Medically Assisted Reproduction Procedure: a Randomised Controlled Study

Study on the effect of the virtual hypnosis mask in addition to local anaesthesia on anxiety and perioperative pain during oocyte puncture

Being tested
local anaesthetic injection, hypnosis with Virtual reality mask

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • local anaesthetic injectionDrug

    Infiltration of 40 to 80 ml of a non-adrenalized 0.5% lidocaine solution into the vaginal wall at the level of the vaginal pouches, under ultrasound guidance. (within the limit of the toxic doses, i.e. 5mg/kg)

  • hypnosis with Virtual reality maskDevice

    A 20-minute virtual reality hypnosis session is performed from the time the patient is placed on the surgical table until the end of the oocyte poncture

Study groups in NCT05567315
Study groupRoleWhat they receive
Oocyte puncture with local anaesthesia aloneActive comparatorNot described
Receives: Drug: local anaesthetic injection
Oocyte puncture with local anaesthesia and additional virtual reality hypnosisExperimentalNot described
Receives: Drug: local anaesthetic injection; Device: hypnosis with Virtual reality mask

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analgesia Nociception Index (ANI) measurement

    The level of pain perceived by the patient during the performance of a painful care procedure will be measured by the ANI index which reflects heart rate variability

    Measured: during oocyte puncture procedure

Secondary outcomes (8)
  1. Anxiety with beck anxiety inventory

    Measurement of anxiety by the Beck Anxiety Inventory, on admission to hospital and on return to the ward, 1 hour after the oocyte puncture

    Measured: 1 hour before intervention and immediately after the intervention

  2. Simulator Sickness Questionnaire (SSQ)

    Assessment of tolerance of virtual reality with SSQ ; SSQ is a scale of cyber sickness from 0 to 48, a higher score mean a worse outcome.

    Measured: Immediately after the intervention

  3. Analog visual scale (AVS)

    Pain evaluation with Analog visual scale by the patient himself from 0 to 10, a higher score mean a worse outcome.

    Measured: Immediately after the intervention

  4. Post intervention analgesic therapy

    Identify the need for postoperative analgesic treatment in the two groups

    Measured: Immediately after the intervention

  5. Total duration of the procedure of oocyte ponction (min)

    Total duration of the procedure (min), from the beginning of local anesthesia to the end of the oocyte retrieval

    Measured: From the first ponction of local anesthesia to the end of the retrieval of the last oocyte

  6. Conversion rate from local anaesthesia to unplanned general anaesthesia

    Conversion rate in percent

    Measured: Immediately after the intervention

  7. Gynecologist's numerical satisfaction scale

    Measure by a numerical scale out of 10, a higher score mean a better outcome.

    Measured: Immediately after the intervention

  8. Patient's numerical satisfaction scale

    Measure by a numerical scale out of 10, a higher score mean a better outcome.

    Measured: Immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2022
  2. Study start11 Oct 2022
  3. Primary completion26 May 2023
  4. Study completion26 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single-centre, comparative, randomised, parallel group study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
182 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05567315
Sponsor's protocol ID
2021-A02136-35
Acronym
HypnoPO
Status last verified
Dec 2023
First submitted
24 Feb 2022
Last updated
11 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing local anaesthetic injection and hypnosis with Virtual reality mask in people with Oocyte Retrieval, run by Clinique Mutualiste la Sagesse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analgesia Nociception Index (ANI) measurement (time frame: during oocyte puncture procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in